Although markets were somewhat shaky for the first big week of the new earnings reporting season, they ultimately closed up for the second week in a row. This is only a small step, but it has proven that solid fundamentals can stabilize this market.
Kanye West, the headline-grabbing entrepreneur and rapper, shared with his 14.9 million Twitter followers this weekend just how much he loves his Tesla. He even garnered the attention of Tesla Inc. (TSLA) CEO Elon Musk, who returned the love in retweet form and reignited the "bromance" be
Pitting Organovo Holdings (NASDAQ:ONVO) against United Therapeutics (NASDAQ:UTHR) might seem a bit strange. Organovo is much smaller than United Therapeutics. Their products have little in common.
However, both of these healthcare stocks have increased by similar levels over the past 12 months. One or both of them could reward investors even more in 2017. Which stock is the better buy now?....More>>>
China Renaissance, a Beijing investment bank and VC/PE investor, plans to expand its investment funds operations, climbing from $3 billion assets under management currently to $10 billion over the next three years. At the moment, the company runs two funds: Huaxing Growth Capital, focused on technology, media and entertainment, and Huaxing Healthcare. The company plans....More>>>
The OPEC deal and two new pipelines to be built in Western Canada saw my favorite oil & gas stocks tick higher – much higher in some cases. And, this should be just the beginning!
As supply and demand come back into balance, Western Canadian producers should find prices sufficient to fund growth without adding to debt. At the same time, the Trans Mountain pipeline will provide access....More>>>
Corcept Therapeutics (NASDAQ:CORT) is my favorite type of biotech company. It has an approved, marketed product with ramping sales, promising pipeline candidates, and is beginning to turn a profit. Both guidance by the company and analyst coverage suggest substantial growth in earnings and revenue. While not without the inherent risks of investing in a small/mid-cap biotech companies,....More>>>
There are lots of articles out there talking about how the smartest move you can make for your retirement is to start saving and investing today. And (of course) if you’re young enough to enjoy the power of compound interest, that is absolutely the best advice out there.
But what about those who are nearing retirement right now? What steps can they take to ensure a healthy and happy....More>>>
Symbiont, a distributed ledger provider, has partnered with Orebits Corp. to offer digitized shares of unrefined gold. Orebits clients can electronically trade smart certificates backed by gold reserves, according to a statement released on Wednesday.
Orebits Corp. provides digitization services to trade commodity reserves.
Active money management is alive and well, at least at T. Rowe Price Group Inc.
The firm attracted $11.3 billion in client cash in the first quarter, the biggest inflow in six years and the second biggest quarterly haul in the company’s history, spokesman Brian Lewbart said in an em
Indonesian equities dropped the most in Asia, with the benchmark gauge sinking to its lowest level since Dec. 15, on concern that Bank Indonesia may raise interest rates for the first time since 2014 to defend the currency, which is already hurting economic growth.
The financial sector was a major part of the Great Recession, and it has been a major part of the recovery and raging bull market since then. Generally speaking, the major financial institutions in the United States are a good barometer of the current state of U.S. markets.
HDFC Bank (HDFCBK) posted strong and in-line with expectations results for Q4FY2018. The bank reported healthy operational performance, as seen in its net interest income (NII) growing by 18% y-o-y to Rs. 10,657 crore and non-interest incom
Airbus SE Chief Executive Officer Tom Enders sketched out the company’s plans for the next generation of European fighter aircraft and warned that Brexit means the U.K. could miss out on future production.
Airbus’s German operation is working with French warplane specialist